Clinical Trials Directory

Trials / Completed

CompletedNCT01996774

Immunologic Profile of Children With Severe Allergies to Peanuts and Nuts After Induction of Tolerance

Immunologic Profile of Children and Teenagers With Severe Allergy to Peanuts and Nuts After Induction of Tolerance: a Pilot Project

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
Lille Catholic University · Academic / Other
Sex
All
Age
1 Year – 17 Years
Healthy volunteers
Accepted

Summary

Many authors propose the strict avoidance of allergenic food as the only treatment for children known to be allergic to certain food. However, it has been observed an increase of the frequency and severity of the allergic accidents in these children in the long term. Other teams have suggested treating these allergies (in particular peanut allergies) by controlled and progressive reintroduction of the allergenic food. A good tolerance and a prevention of allergic reactions consecutive to the ingestion of the same allergenic food were observed. The immunological mechanisms of this type of treatment are not well known. A decrease of specific IgE and an increase of IgG4 have been observed in the case of egg allergies after this kind of treatment. Certain experiments realized in mice models testing the allergenic stimulation challenge showed an increase of lymphocytes T regulators (foxp3+ , CD4+, CD25+), stimulated by dendritic cells, and also an increase of interleukin 10, leading to the modification of the balance between Th1 and Th2.Our hypothesis is that after treating allergies by the reintroduction of the allergenic food, the immunological mechanism of acquisition of tolerance is associated to variations in populations of lymphocytes and in the activation or decrease of pro and anti-inflammatory cytokines. This reaction will be studied in two groups: 1. Children with a confirmed allergy to peanuts or nuts and 2. Children without antecedents of allergy or familiar atopy.

Conditions

Timeline

Start date
2012-02-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2013-11-27
Last updated
2014-08-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01996774. Inclusion in this directory is not an endorsement.